antianginal efficacy was assessed by the number of episodes of angina and nitroglycerin tablets consumed during each 2-week period , as well as the number of episodes of ischemia during 48-hour ambulatory monitoring and the area and severity of st-segment depression during 16-point precordial exercise mapping .
C1874267
antianginal
C0002962
angina